Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left main coronary artery disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical Endpoint- Target Lesion Failure (TLF)
Timeframe: 12 months post-procedure
Efficacy Endpoint - Angiographic Success
Timeframe: 12 months post-procedure